PRESS RELEASE published on 02/06/2024 at 14:01, 1 year 11 months ago MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY Mainz Biomed N.V. (NASDAQ:MYNZ) has established the 'European Oncology Lab' (EOL), a physician-led laboratory for expanding service offering to privately insured patients in Germany. The lab will offer ColoAlert® as a laboratory medical service directly to physicians and patients, addressing the crucial requirement for invoicing private health insurance companies Germany Mainz Biomed N.V. European Oncology Lab ColoAlert Privately Insured Patients
PRESS RELEASE published on 11/09/2023 at 14:01, 2 years 2 months ago Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
PRESS RELEASE published on 11/07/2023 at 14:01, 2 years 2 months ago Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
PRESS RELEASE published on 10/31/2023 at 13:01, 2 years 2 months ago Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
PRESS RELEASE published on 10/26/2023 at 14:01, 2 years 3 months ago Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
PRESS RELEASE published on 10/18/2023 at 14:01, 2 years 3 months ago Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
PRESS RELEASE published on 10/11/2023 at 14:01, 2 years 3 months ago Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
PRESS RELEASE published on 10/05/2023 at 14:01, 2 years 3 months ago Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit
PRESS RELEASE published on 10/04/2023 at 14:01, 2 years 3 months ago Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania
PRESS RELEASE published on 09/27/2023 at 14:01, 2 years 4 months ago Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology
Published on 01/30/2026 at 14:00, 3 hours 53 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 9 hours 18 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 9 hours 53 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 15 hours 38 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 17 hours 53 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 17:29, 24 minutes ago EQS-Adhoc: The Payments Group Holding GmbH & Co. KGaA: The Payments Group Holding – Successful issuance of convertible bond
Published on 01/30/2026 at 16:46, 1 hour 7 minutes ago Custodian Property Income REIT plc: Investor Presentation via Investor Meet Company
Published on 01/30/2026 at 16:00, 1 hour 53 minutes ago Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation
Published on 01/30/2026 at 17:45, 8 minutes ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 23 hours 53 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
